In this presentation, Dr Angela George, Clinical Director (Cancer) of the North Thames GLH explores the role of the NHS genomic medicines service in delivering cancer genomic testing via the regional network of GLH’s.
Recorded in June 2021 as part of The Genomic Medicine Service and NTRK Tumour Agnostic Testing and Treatment Pathways in Solid Tumours virtual meeting. You can view the other presentations from the meeting by following the links below;
- Genomic testing in cancer: NTRK testing and reporting pathways. Dr Mike Hubank, Scientific Director, North Thames GLH
- Genomic testing in cancer: NTRK Sample requirements, tumour assessments and optimising tissue pathways. Professor Louise Jones, Pathology Lead, North Thames GLH
- The NTRK testing and treatment landscape and patient case study: A clinician’s perspective. Dr Martin Forster, Associate Professor and Consultant in Medical Oncology UCL Cancer Institute. This presentation was sponsored by Bayer and the video is hosted on a Bayer promotional website. To leave the North Thames GLH website and access this presentation on the Bayer website, please click here